(Q58289592)

English

A short report on the highlights of world-wide development of RIX4414: a North American experience

article

In more languages
default for all languages
No label defined

No description defined

Statements

A short report on the highlights of world-wide development of RIX4414: a North American experience comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine (RIX4414) in infants in the United States and Canada (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit